Ginsenoside Rg1 promotes non-rapid eye movement sleep via inhibition of orexin neurons of the lateral hypothalamus and corticotropin-releasing hormone neurons of the paraventricular hypothalamic nucleus.
10.1016/j.joim.2024.11.001
- Author:
Yi-Yuan WANG
1
;
Yi WU
2
;
Ke-Wei YU
1
;
Hong-Yu XIE
1
;
Yi GUI
1
;
Chang-Rui CHEN
3
,
4
;
Nian-Hong WANG
5
Author Information
1. Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China; National Center for Neurological Disorders, Shanghai 200040, China; National Clinical Research Center for Geriatric Diseases, Shanghai 200040, China.
2. Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China; National Center for Neurological Disorders, Shanghai 200040, China; National Clinical Research Center for Geriatric Diseases, Shanghai 200040, China; School of Rehabilitation Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
3. Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai 200040, China. Electronic address: changruichen@
4. com.
5. Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China; National Center for Neurological Disorders, Shanghai 200040, China; National Clinical Research Center for Geriatric Diseases, Shanghai 200040, China; School of Rehabilitation Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: wnh@fudan.edu.cn.
- Publication Type:Research Support, Non-U.S. Gov't
- Keywords:
Ginsenoside Rg1;
Insomnia;
Lateral hypothalamus;
Non-rapid eye movement;
Paraventricular hypothalamic nucleus
- MeSH:
Animals;
Ginsenosides/pharmacology*;
Orexins/metabolism*;
Mice, Inbred C57BL;
Neurons/metabolism*;
Paraventricular Hypothalamic Nucleus/metabolism*;
Male;
Hypothalamic Area, Lateral/metabolism*;
Corticotropin-Releasing Hormone/metabolism*;
Mice;
Sleep/drug effects*
- From:
Journal of Integrative Medicine
2024;22(6):719-728
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:This study investigates the sleep-modulating effects of ginsenoside Rg1 (Rg1, C42H72O14), a key bioactive component of ginseng, and elucidates its underlying mechanisms.
METHODS:C57BL/6J mice were intraperitoneally administered doses of Rg1 ranging from 12.5 to 100 mg/kg. Sleep parameters were assessed to determine the average duration of each sleep stage by monitoring the electrical activity of the brain and muscles. Further, orexin neurons in the lateral hypothalamus (LH) and corticotropin-releasing hormone (CRH) neurons in the paraventricular hypothalamic nucleus (PVH) were ablated using viral vector surgery and electrode embedding. The excitability of LHorexin and PVHCRH neurons was evaluated through the measurement of cellular Finkel-Biskis-Jinkins murine osteosarcoma viral oncogene homolog (c-Fos) expression.
RESULTS:Rg1 (12.5-100 mg/kg) augmented the duration of non-rapid eye movement (NREM) sleep phases, while reducing the duration of wakefulness, in a dose dependent manner. The reduced latency from wakefulness to NREM sleep indicates an accelerated sleep initiation time. We found that these sleep-promoting effects were weakened in the LHorexin and PVHCRH neuron ablation groups, and disappeared in the orexin and CRH double-ablation group. Decreased c-Fos protein expression in the LH and PVH confirmed that Rg1 promoted NREM sleep by inhibiting orexin and CRH neurons.
CONCLUSION:Rg1 increases the duration of NREM sleep, underscoring the essential roles of LHorexin and PVHCRH neurons in facilitating the sleep-promoting effects of Rg1. Please cite this article as: Wang YY, Wu Y, Yu KW, Xie HY, Gui Y, Chen CR, Wang NH. Ginsenoside Rg1 promotes non-rapid eye movement sleep via inhibition of orexin neurons of the lateral hypothalamus and corticotropin-releasing hormone neurons of the paraventricular hypothalamic nucleus. J Integr Med. 2024; 22(6): 721-730.
